Invivyd, Inc. (IVVD) Posts Positive Phase 3 LIBERTY Data, Plans Accelerated BLA
Invivyd reported positive topline Phase 3 LIBERTY data showing VYD2311 safety/tolerability favorable vs an mRNA COVID-19 vaccine and no immunologic interference, and said it intends to submit a BLA under the FDA Accelerated Approval Program pending DECLARATION results.Material DetailsContext by AI…